Effectiveness of Tumor Necrosis Factor Inhibitors in Combination with Various csDMARD in the Treatment of Rheumatoid Arthritis: Data from the DREAM Registry.
CONCLUSION: Preferably, TNFi should be prescribed together with MTX. If this is not possible, we advise the use of other csDMARD.
PMID: 27481900 [PubMed - as supplied by publisher]
Source: J Rheumatol - Category: Rheumatology Authors: Manders SH, Kievit W, Jansen TL, Stolk JN, Visser H, Schilder AM, Vonkeman HE, Adang E, van de Laar MA, van Riel PL Tags: J Rheumatol Source Type: research
More News: Arthritis | Disability | Health | Methotrexate | Rheumatoid Arthritis | Rheumatology | Study